Kazia Therapeutics Ltd SEC filings KZIA

Kazia Therapeutics Ltd has 1,000 filings in SEC EDGAR's recent list, going back to May 1, 2007. Its latest annual report, Form 20-F, was filed on Nov 7, 2025 for the period ended Jun 30, 2025. The most recent current report (Form 6-K) was filed on Sep 22, 2026. The company's fiscal year ends on June 30.

Kazia Therapeutics Ltd SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 19, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Jul 8, 2026 Jan 8, 2026
4 Insider transaction Jul 8, 2026 Jan 8, 2026
4 Insider transaction Jul 8, 2026 Jan 8, 2026
4 Insider transaction Jul 8, 2026 Jan 8, 2026
4 Insider transaction Jul 8, 2026 Jan 8, 2026
4 Insider transaction Jul 8, 2026 Jan 8, 2026
4 Insider transaction Jun 23, 2026 Jun 19, 2026
4 Insider transaction Jun 23, 2026 Jun 19, 2026
3 Initial insider ownership Jun 15, 2026 Jun 1, 2026
3 Initial insider ownership Jun 3, 2026 Mar 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 27, 2026 —
3 Initial insider ownership May 19, 2026 Apr 13, 2026
3/A Filing Apr 9, 2026 Mar 18, 2026
3 Initial insider ownership Apr 1, 2026 Mar 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 31, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 30, 2026 —
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 20, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 23, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jun 13, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jun 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 19, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 16, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Aug 12, 2024 —
SC 13G Ownership over 5% (passive) Jul 2, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 5, 2016 —
SC 13G Ownership over 5% (passive) Jul 2, 2015 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2015 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2014 —
SC 13D/A Amended ownership over 5% (active) Nov 25, 2013 —
4 Insider transaction Nov 6, 2013 Nov 4, 2013
SC 13D/A Amended ownership over 5% (active) Nov 4, 2013 —
4 Insider transaction Oct 29, 2013 Oct 25, 2013
SC 13D/A Amended ownership over 5% (active) Oct 22, 2013 —
4 Insider transaction Oct 17, 2013 Oct 15, 2013
SC 13D/A Amended ownership over 5% (active) Mar 7, 2013 —
4 Insider transaction Feb 27, 2013 Feb 25, 2013
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2013 —
SC 13D/A Amended ownership over 5% (active) Dec 7, 2012 —
4 Insider transaction Dec 5, 2012 Dec 3, 2012
4 Insider transaction Nov 21, 2012 Nov 20, 2012
SC 13D/A Amended ownership over 5% (active) Oct 19, 2012 —
SC 13D/A Amended ownership over 5% (active) May 25, 2012 —
4 Insider transaction May 15, 2012 May 11, 2012
SC 13G Ownership over 5% (passive) Apr 9, 2012 —
SC 13D/A Amended ownership over 5% (active) Jan 5, 2012 —
4 Insider transaction Dec 30, 2011 Dec 29, 2011
SC 13D/A Amended ownership over 5% (active) Oct 5, 2011 —
4 Insider transaction Oct 5, 2011 Sep 30, 2011
SC 13D/A Amended ownership over 5% (active) May 11, 2011 —
4 Insider transaction May 10, 2011 May 9, 2011
SC 13D/A Amended ownership over 5% (active) Dec 30, 2010 —
SC 13D/A Amended ownership over 5% (active) Aug 8, 2008 —
SC 13D Ownership over 5% (active) Aug 7, 2008 —
4 Insider transaction Jul 31, 2008 Jul 29, 2008
4 Insider transaction Jul 30, 2008 Jul 28, 2008
4 Insider transaction Mar 27, 2008 Mar 25, 2008
SC 13D/A Amended ownership over 5% (active) Sep 20, 2007 —
4 Insider transaction Sep 11, 2007 Sep 10, 2007
SC 13D/A Amended ownership over 5% (active) Jul 20, 2007 —
4 Insider transaction Jul 12, 2007 Jul 10, 2007
SC 13D/A Amended ownership over 5% (active) Jul 3, 2007 —
4 Insider transaction Jul 2, 2007 Jun 28, 2007
4 Insider transaction Jun 26, 2007 Jun 22, 2007
4 Insider transaction Jun 22, 2007 Jun 20, 2007
4 Insider transaction Jun 20, 2007 Jun 18, 2007
4 Insider transaction Jun 18, 2007 Jun 14, 2007
4 Insider transaction Jun 14, 2007 Jun 12, 2007
4 Insider transaction Jun 12, 2007 Jun 8, 2007
4 Insider transaction Jun 8, 2007 Jun 6, 2007
4 Insider transaction Jun 5, 2007 Jun 1, 2007
4 Insider transaction Jun 1, 2007 May 30, 2007
4 Insider transaction May 30, 2007 May 25, 2007
4 Insider transaction May 25, 2007 May 23, 2007
4 Insider transaction May 23, 2007 May 21, 2007
4 Insider transaction May 18, 2007 May 16, 2007

Showing 93 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KZIA (Nasdaq)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Sydney Nsw
SEC filer status
Non-accelerated filer
SEC CIK
1075880
Former names
NOVOGEN LTD (until Nov 17, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.